Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT00790816
Title Continuation Study of Lapatinib Monotherapy or Lapatinib in Combination With Other Anti-cancer Agents
Recruitment Completed
Gender both
Phase Phase I
Variant Requirements No
Sponsors GlaxoSmithKline
Indications

Advanced Solid Tumor

Therapies

Lapatinib + Paclitaxel

Lapatinib

Lapatinib + Trastuzumab

Capecitabine + Lapatinib

Lapatinib + Letrozole

Capecitabine + Lapatinib + Oxaliplatin

Gemcitabine + Lapatinib

Docetaxel + Lapatinib

Fluorouracil + Lapatinib + Leucovorin + Oxaliplatin

Fluorouracil + Irinotecan + Lapatinib + Leucovorin

Age Groups: adult
Covered Countries USA | ESP | CAN


No variant requirements are available.